STOCK TITAN

Biotech Firm SciSparc Gets Green Light for Executive Pay Plan and Governance Updates

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

SciSparc announced that shareholders approved all proposals at their adjourned annual general meeting held on June 26, 2025. The meeting resulted in the approval of two significant documents:

  • A new amended and restated articles of association
  • An updated compensation policy for executive officers and directors

These approvals were obtained with the requisite majority in accordance with Israeli Companies Law and the company's existing articles of association. The proposals were previously detailed in a proxy statement furnished to the SEC on May 21, 2025.

The Form 6-K filing will be incorporated into multiple company registration statements, including several Form F-3s (File Nos. 333-286099, 333-275305, 333-269839, 333-266047, 333-248670, 333-255408) and Form S-8s (File Nos. 333-278437, 333-225773, 333-286791). The document was signed by Oz Adler, Chief Executive Officer.

Positive

  • None.

Negative

  • None.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

 

For the month of June 2025 (Report No. 4)

 

Commission file number: 001- 38041

 

SCISPARC LTD.

(Translation of registrant’s name into English)

 

20 Raul Wallenberg Street, Tower A,

Tel Aviv 6971916 Israel

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F Form 40-F 

 

 

 

 

CONTENTS

 

SciSparc Ltd. (the “Company”) hereby announces that the shareholders of the Company approved all of the proposals brought before the adjourned annual general meeting of shareholders held on June 26, 2025 (the “Meeting”), by the respective requisite majority in accordance with the Israeli Companies Law, 5759-1999, and the Company’s amended and restated articles of association, as described in the Proxy Statement which was attached as Exhibit 99.1 to the Company’s Report of Foreign Private Issuer on Form 6-K, furnished to the Securities and Exchange Commission (the “SEC”) on May 21, 2025, and sent to shareholders in connection with the Meeting.

 

A copy of the Company’s amended and restated articles of association, approved by shareholders at the Meeting, is attached hereto as Exhibit 99.1.

 

A copy of the Company’s compensation policy, approved by shareholders at the Meeting, is attached hereto as Exhibit 99.2.

 

This Report of Foreign Private Issuer on Form 6-Kis incorporated by reference into the Company’s registration statements on Form F-3 (File Nos. 333-286099, 333-275305, 333-269839, 333-266047, 333-248670 and 333-255408) and on Form S-8 (File Nos. 333-278437, 333-225773 and 333-286791) filed with the SEC to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

 

- 1 -

 

Exhibits No.    
99.1   Amended and Restated Articles of Association.
     
99.2   Compensation Policy for Executive Officers and Directors.

 

- 2 -

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  SciSparc Ltd.
   
Date: June 26, 2025 By: /s/ Oz Adler
    Name: Oz Adler
Title: Chief Executive Officer

 

 

- 3 -

 

FAQ

What was approved at SPRC's annual general meeting on June 26, 2025?

At SPRC's annual general meeting on June 26, 2025, shareholders approved all proposals presented, including a new amended and restated articles of association and a new compensation policy for executive officers and directors. The proposals were approved by the required majority in accordance with Israeli Companies Law.

When did SPRC file its latest Form 6-K and what was it about?

SPRC filed a Form 6-K on June 28, 2025 (Report No. 4) to announce the results of their annual general meeting held on June 26, 2025. The filing included information about shareholder approvals and new corporate documents.

Who is the current CEO of SPRC as of June 2025?

According to the Form 6-K filing's signature page, Oz Adler is serving as the Chief Executive Officer of SciSparc Ltd. as of June 2025.

What SEC registration statements does SPRC's June 2025 6-K filing affect?

The 6-K filing is incorporated into SPRC's Form F-3 registration statements (File Nos. 333-286099, 333-275305, 333-269839, 333-266047, 333-248670, and 333-255408) and Form S-8 registration statements (File Nos. 333-278437, 333-225773, and 333-286791).

Where is SPRC's principal executive office located?

SPRC's principal executive office is located at 20 Raul Wallenberg Street, Tower A, Tel Aviv 6971916, Israel.
Scisparc

NASDAQ:SPRC

View SPRC Stock Overview

SPRC Rankings

SPRC Latest News

SPRC Latest SEC Filings

SPRC Stock Data

2.26M
517.11k
Biotechnology
Healthcare
Link
Israel
Tel Aviv-Yafo